Sage Journals: Discover world-class research

Retricted access

Research article

First published 2012-9

Professional Development Through Planning for and/or Participating in an Accreditation/Approval Review

Sharon Davis, James F. McKenzie, Sue Baldwin [...]

Health Promotion Practice

Retricted access

Research article

First published 2013-3

Factors Related to Regulatory Approval of Late-Stage Development Compounds

Atsushi Tsukamoto, Masayuki Kaneko, Mamoru Narukawa

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2020-3

Transnational urbanism interrupted: A Chinese developer’s attempts to secure approval to build the ‘New York of Africa’ at Modderfontein,Johannesburg

Richard Ballard, Philip Harrison

Environment and Planning A: Economy and Space

Retricted access

Other

First published 1997-10

Good Statistics Practice in the Drug Development and Regulatory Approval Process

Shein-Chung Chow

Therapeutic Innovation & Regulatory Science

Open access

Review article

First published 2023

Ethical challenges and opportunities in the development and approval of novel therapeutics for rare diseases

Djurdja Djordjevic, Andrew McFadyen, James A Anderson

The Journal of Medicine Access

Retricted access

Research article

First published 2015-11

The Relationship Between Development Start Lag and Approval Lag in Oncology Drug Development in Japan

Keitaro Nakajima, Ramzi Dagher, Laurie Strawn [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2015-04

Development of Drug-Approval Regulations for Medical Countermeasures Against CBRN Agents in Japan

Rumiko Shimazawa, Masayuki Ikeda

Health Security

Retricted access

Research article

First published 2000-06

The Development of a Measure of Desired Moral Approbation

Lori Verstegen Ryan, Christine M. Riordan

Educational and Psychological Measurement

Retricted access

Research article

First published 2019-11

Clinical Development of Biologics Approved by the US Food and Drug Administration,2003-2016

G. Caleb Alexander, Ken Ogasawara, Dana Wiegand [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Other

First published 2000-1

The New Drug Approvals of 1996,1997,and 1998: Drug Development Trends in the User Fee Era *

Kenneth I. Kaitin, Elaine M. Healy

Therapeutic Innovation & Regulatory Science

Search results